CDC-RFA-PS23-2306: Community-Based Approaches to Reducing Sexually Transmitted Diseases (CARS)
Closed
This grant is closed. A newer notice from the same program is forecast: Controlling and Preventing STIs in US Health Departments (CAP-STIs) (CDC-RFA-PS-27-0008). Status: Expected deadline January 11, 2027. It is in our archive of Centers for Disease Control - NCHHSTP notices from 2023.
Centers for Disease Control - NCHHSTP offered grants of up to $325,000 (at least $250,000) to any type of organization. It expected to make about 4 awards worth $3.9 million in total. Applications closed on June 27, 2023.
From the official notice on Grants.gov, last changed May 3, 2023. Checked November 7, 2026.
- Award ceiling$325,000
- Award floor$250,000
- Total funding$3.9 million
- Expected awards4
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | April 28, 2023 |
|---|---|
| Deadline | June 27, 2023 |
| Archived by Grants.gov | August 3, 2023 |
Who can apply
This opportunity was open to any type of organization.
All 16 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
N/A
Is this a realistic fit?
- Past Sexually Transmitted Diseases (STD) Prevention and Control Grants awards averaged $6.1 million; this notice allows up to $325,000 per award.
- Most of the program's money (97% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
CDC proposes to allocate funds to implement Notice of Funding Opportunity (NOFO) CDC-RFA-PS23-0006, Community-Based Approaches to Reducing Sexually Transmitted Diseases. The project period will be Three years, with three12-month budget periods and an anticipated project start date of September 30, 2023. The purpose of this NOFO is to implement community engagement methods to achieve health equity, via the identification and implementation of structural strategies promoting personal health. Recipients will support healthy behaviors, facilitate community-clinical linkages to build support for interventions to prevent and reduce STD disparities, enhance and sustain partnerships, support communication strategies that promote STD program successes and leverage additional resources for STD, HIV, viral hepatitis control and prevention, and evaluate the efficacy of this intervention approach. The new FOA provides support in five focus areas: (1) implementation of community engagement methods (e.g. community-based participatory research) to achieve health equity; (2) identification and implementation of systems and environmental change strategies that (a) promote sexual health and support healthy behaviors and (b) facilitate community-clinical linkages to build support for interventions to prevent and reduce STI disparities; (3) enhancement and sustainability of partnerships; (4) support for communication strategies to promote STD program successes and leverage additional resources for STI control and prevention; and (5) evaluation of the efficacy of this approach and intervention implementation.
Who has won Sexually Transmitted Diseases (STD) Prevention and Control Grants grants before
From fiscal 2021 to 2025, Sexually Transmitted Diseases (STD) Prevention and Control Grants (93.977) awarded $1.2 billion across 189 grant awards, an average of $6.1 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Department of State Health Services | Texas | 2 | $94.0 million |
| California Department of Public Health | California | 3 | $85.2 million |
| Florida Department of Health | Florida | 4 | $73.7 million |
| City of New York | New York | 5 | $48.7 million |
| County of Los Angeles | California | 2 | $37.1 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, CDC-RFA-PS-27-0008, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-PS23-2306 still open?
No. It closed on June 27, 2023. A newer notice is forecast: CDC-RFA-PS-27-0008, expected deadline January 11, 2027.
Who can apply for Community-Based Approaches to Reducing Sexually Transmitted Diseases (CARS)?
Centers for Disease Control - NCHHSTP accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Community-Based Approaches to Reducing Sexually Transmitted Diseases (CARS)?
Closed June 27, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $325,000 each. About $3.9 million in total across about 4 awards.
Who has won Sexually Transmitted Diseases (STD) Prevention and Control Grants grants before?
The largest recipients over five fiscal years were Department of State Health Services, California Department of Public Health, Florida Department of Health. The program made 189 awards worth $1.2 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)